Review



human mantle cell lymphoma mcl cell lines mino  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    ATCC human mantle cell lymphoma mcl cell lines mino
    Co-culture of <t>MCL</t> cells with macrophages. (A-B) The M2-to-M1 ratio of macrophages from both ibrutinib-sensitive and −resistant subjects was analyzed using macrophage samples derived <t>from</t> <t>lymphoma</t> and blood. (C) Enrichment analysis of the KEGG signaling pathways conducted using the “clusterProfiler” package revealed significantly enriched KEGG pathways associated with correlated protein-coding genes. (D) A schematic diagram of the co-culture system illustrates MCL cells located on the upper side and macrophages on the lower side, separated by polycarbonate pore membranes with a pore size of 0.4 μm. (E) Mino and JEKO-1 cells were treated with the indicated concentrations of ibrutinib, with or without macrophages. Cell viability was evaluated using the CCK-8 assay, and control cells were treated with DMSO. (F-G) Cell apoptosis ratios were analyzed by flow cytometry. Mino and JEKO-1 cells were treated with either DMSO or 1 μM ibrutinib, and the percentages of Annexin V/PI (propidium iodide)-positive cells were measured. ****p < 0.0001.
    Human Mantle Cell Lymphoma Mcl Cell Lines Mino, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mantle+cell+lymphoma+mcl+cell+lines/Mino%3B+Mantle+Cell+Lymphoma%3B+Human/pmc12225943-37-0-14
    Average 93 stars, based on 9 article reviews
    human mantle cell lymphoma mcl cell lines mino - by Bioz Stars, 2026-10
    93/100 stars

    Images

    1) Product Images from "Dialog between mantle cell lymphoma cells and lymphoma-associated macrophages underlies ibrutinib resistance"

    Article Title: Dialog between mantle cell lymphoma cells and lymphoma-associated macrophages underlies ibrutinib resistance

    Journal: Journal of Advanced Research

    doi: 10.1016/j.jare.2024.08.023

    Co-culture of MCL cells with macrophages. (A-B) The M2-to-M1 ratio of macrophages from both ibrutinib-sensitive and −resistant subjects was analyzed using macrophage samples derived from lymphoma and blood. (C) Enrichment analysis of the KEGG signaling pathways conducted using the “clusterProfiler” package revealed significantly enriched KEGG pathways associated with correlated protein-coding genes. (D) A schematic diagram of the co-culture system illustrates MCL cells located on the upper side and macrophages on the lower side, separated by polycarbonate pore membranes with a pore size of 0.4 μm. (E) Mino and JEKO-1 cells were treated with the indicated concentrations of ibrutinib, with or without macrophages. Cell viability was evaluated using the CCK-8 assay, and control cells were treated with DMSO. (F-G) Cell apoptosis ratios were analyzed by flow cytometry. Mino and JEKO-1 cells were treated with either DMSO or 1 μM ibrutinib, and the percentages of Annexin V/PI (propidium iodide)-positive cells were measured. ****p < 0.0001.
    Figure Legend Snippet: Co-culture of MCL cells with macrophages. (A-B) The M2-to-M1 ratio of macrophages from both ibrutinib-sensitive and −resistant subjects was analyzed using macrophage samples derived from lymphoma and blood. (C) Enrichment analysis of the KEGG signaling pathways conducted using the “clusterProfiler” package revealed significantly enriched KEGG pathways associated with correlated protein-coding genes. (D) A schematic diagram of the co-culture system illustrates MCL cells located on the upper side and macrophages on the lower side, separated by polycarbonate pore membranes with a pore size of 0.4 μm. (E) Mino and JEKO-1 cells were treated with the indicated concentrations of ibrutinib, with or without macrophages. Cell viability was evaluated using the CCK-8 assay, and control cells were treated with DMSO. (F-G) Cell apoptosis ratios were analyzed by flow cytometry. Mino and JEKO-1 cells were treated with either DMSO or 1 μM ibrutinib, and the percentages of Annexin V/PI (propidium iodide)-positive cells were measured. ****p < 0.0001.

    Techniques Used: Co-Culture Assay, Derivative Assay, Protein-Protein interactions, Pore Size, CCK-8 Assay, Control, Flow Cytometry

    Combination of CXCR2 inhibitor and ibrutinib displayed high synergistic inhibition of MCL growth. (A, B) The apoptosis of ibrutinib-treated cells was assessed using flow cytometry following treatment with CXCL5 or co-culture conditions. (C) Caspase-3 activity in Mino and JEKO-1 cells was measured under CXCL5 or co-culture treatments. (D) Compusyn software was employed to analyze the inhibition rates of malignant cells (MCLs) under ibrutinib, SB225002, and the combination of ibrutinib and SB225002 in a co-culture system. (E) The combined drug index (CI) of ibrutinib combined with SB225002 was analyzed using Compusyn software at different inhibition rates. (F) The dose-reduction index (DRI) of ibrutinib and SB225002 is presented. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Fa: Fraction affected.
    Figure Legend Snippet: Combination of CXCR2 inhibitor and ibrutinib displayed high synergistic inhibition of MCL growth. (A, B) The apoptosis of ibrutinib-treated cells was assessed using flow cytometry following treatment with CXCL5 or co-culture conditions. (C) Caspase-3 activity in Mino and JEKO-1 cells was measured under CXCL5 or co-culture treatments. (D) Compusyn software was employed to analyze the inhibition rates of malignant cells (MCLs) under ibrutinib, SB225002, and the combination of ibrutinib and SB225002 in a co-culture system. (E) The combined drug index (CI) of ibrutinib combined with SB225002 was analyzed using Compusyn software at different inhibition rates. (F) The dose-reduction index (DRI) of ibrutinib and SB225002 is presented. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Fa: Fraction affected.

    Techniques Used: Inhibition, Flow Cytometry, Co-Culture Assay, Activity Assay, Software

    Related Articles

    other:

    Article Title: ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors
    Article Snippet: The human mantle cell lymphoma (MCL) cell lines (REC-1, JeKo-1, Z-138, Mino, JVM-2, JVM-13), Burkitt lymphoma (BL) cell lines (Raji, EB1, DaudiI, Ramos, and CA46) and solid tumors cell lines were obtained from ATCC (American Type Culture Collection).

    Article Title: Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma
    Article Snippet: The human mantle cell lymphoma (MCL) cell lines (REC-1, JeKo-1, Z-138, Mino, JVM-2, JVM-13), Burkitt lymphoma (BL) cell lines (Raji, EB1, Daudi, Ramos, and CA46) and solid tumors cell lines were obtained from ATCC (American Type Culture Collection).

    Article Title: Discovery of Asn007, a Novel Inhibitor of Erk1/2, with a Preferential Activity in RAS- and RAF-Mutant Tumors
    Article Snippet: Affiliations 1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 2Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, 3Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, NY, 4Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, 5Asana BioSciences, Lawrenceville, New Jersey, USA.

    Article Title: Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma.
    Article Snippet: The human mantle cell lymphoma (MCL) cell lines (REC-1, JeKo-1, Z138, Mino, JVM-2, JVM-13), Burkitt lymphoma (BL) cell lines (Raji, EB1, Daudi, Ramos, and CA46) and solid tumors cell lines were obtained from ATCC (American Type Culture Collection).



    Similar Products

    human mantle cell lymphoma mcl cell lines mino  (ATCC)
    93
    ATCC human mantle cell lymphoma mcl cell lines mino
    Co-culture of <t>MCL</t> cells with macrophages. (A-B) The M2-to-M1 ratio of macrophages from both ibrutinib-sensitive and −resistant subjects was analyzed using macrophage samples derived <t>from</t> <t>lymphoma</t> and blood. (C) Enrichment analysis of the KEGG signaling pathways conducted using the “clusterProfiler” package revealed significantly enriched KEGG pathways associated with correlated protein-coding genes. (D) A schematic diagram of the co-culture system illustrates MCL cells located on the upper side and macrophages on the lower side, separated by polycarbonate pore membranes with a pore size of 0.4 μm. (E) Mino and JEKO-1 cells were treated with the indicated concentrations of ibrutinib, with or without macrophages. Cell viability was evaluated using the CCK-8 assay, and control cells were treated with DMSO. (F-G) Cell apoptosis ratios were analyzed by flow cytometry. Mino and JEKO-1 cells were treated with either DMSO or 1 μM ibrutinib, and the percentages of Annexin V/PI (propidium iodide)-positive cells were measured. ****p < 0.0001.
    Human Mantle Cell Lymphoma Mcl Cell Lines Mino, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mantle+cell+lymphoma+mcl+cell+lines/Mino%3B+Mantle+Cell+Lymphoma%3B+Human/pmc12225943-37-0-14
    Average 93 stars, based on 1 article reviews
    human mantle cell lymphoma mcl cell lines mino - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    human mantle cell lymphoma mcl cell lines  (ATCC)
    96
    ATCC human mantle cell lymphoma mcl cell lines
    Co-culture of <t>MCL</t> cells with macrophages. (A-B) The M2-to-M1 ratio of macrophages from both ibrutinib-sensitive and −resistant subjects was analyzed using macrophage samples derived <t>from</t> <t>lymphoma</t> and blood. (C) Enrichment analysis of the KEGG signaling pathways conducted using the “clusterProfiler” package revealed significantly enriched KEGG pathways associated with correlated protein-coding genes. (D) A schematic diagram of the co-culture system illustrates MCL cells located on the upper side and macrophages on the lower side, separated by polycarbonate pore membranes with a pore size of 0.4 μm. (E) Mino and JEKO-1 cells were treated with the indicated concentrations of ibrutinib, with or without macrophages. Cell viability was evaluated using the CCK-8 assay, and control cells were treated with DMSO. (F-G) Cell apoptosis ratios were analyzed by flow cytometry. Mino and JEKO-1 cells were treated with either DMSO or 1 μM ibrutinib, and the percentages of Annexin V/PI (propidium iodide)-positive cells were measured. ****p < 0.0001.
    Human Mantle Cell Lymphoma Mcl Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mantle+cell+lymphoma+mcl+cell+lines/Z-138/pm36934096-181-1-33
    Average 96 stars, based on 1 article reviews
    human mantle cell lymphoma mcl cell lines - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier
    human mantle cell lymphoma mcl cell lines jeko 1  (ATCC)
    96
    ATCC human mantle cell lymphoma mcl cell lines jeko 1
    Co-culture of <t>MCL</t> cells with macrophages. (A-B) The M2-to-M1 ratio of macrophages from both ibrutinib-sensitive and −resistant subjects was analyzed using macrophage samples derived <t>from</t> <t>lymphoma</t> and blood. (C) Enrichment analysis of the KEGG signaling pathways conducted using the “clusterProfiler” package revealed significantly enriched KEGG pathways associated with correlated protein-coding genes. (D) A schematic diagram of the co-culture system illustrates MCL cells located on the upper side and macrophages on the lower side, separated by polycarbonate pore membranes with a pore size of 0.4 μm. (E) Mino and JEKO-1 cells were treated with the indicated concentrations of ibrutinib, with or without macrophages. Cell viability was evaluated using the CCK-8 assay, and control cells were treated with DMSO. (F-G) Cell apoptosis ratios were analyzed by flow cytometry. Mino and JEKO-1 cells were treated with either DMSO or 1 μM ibrutinib, and the percentages of Annexin V/PI (propidium iodide)-positive cells were measured. ****p < 0.0001.
    Human Mantle Cell Lymphoma Mcl Cell Lines Jeko 1, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mantle+cell+lymphoma+mcl+cell+lines/JeKo-1/pmc08445847-271-0-36
    Average 96 stars, based on 1 article reviews
    human mantle cell lymphoma mcl cell lines jeko 1 - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier
    human mantle cell lymphoma mcl jeko 1 cell line  (ATCC)
    96
    ATCC human mantle cell lymphoma mcl jeko 1 cell line
    Co-culture of <t>MCL</t> cells with macrophages. (A-B) The M2-to-M1 ratio of macrophages from both ibrutinib-sensitive and −resistant subjects was analyzed using macrophage samples derived <t>from</t> <t>lymphoma</t> and blood. (C) Enrichment analysis of the KEGG signaling pathways conducted using the “clusterProfiler” package revealed significantly enriched KEGG pathways associated with correlated protein-coding genes. (D) A schematic diagram of the co-culture system illustrates MCL cells located on the upper side and macrophages on the lower side, separated by polycarbonate pore membranes with a pore size of 0.4 μm. (E) Mino and JEKO-1 cells were treated with the indicated concentrations of ibrutinib, with or without macrophages. Cell viability was evaluated using the CCK-8 assay, and control cells were treated with DMSO. (F-G) Cell apoptosis ratios were analyzed by flow cytometry. Mino and JEKO-1 cells were treated with either DMSO or 1 μM ibrutinib, and the percentages of Annexin V/PI (propidium iodide)-positive cells were measured. ****p < 0.0001.
    Human Mantle Cell Lymphoma Mcl Jeko 1 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mantle+cell+lymphoma+mcl+cell+lines/JeKo-1/pmc06096197-169-1-23
    Average 96 stars, based on 1 article reviews
    human mantle cell lymphoma mcl jeko 1 cell line - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Co-culture of MCL cells with macrophages. (A-B) The M2-to-M1 ratio of macrophages from both ibrutinib-sensitive and −resistant subjects was analyzed using macrophage samples derived from lymphoma and blood. (C) Enrichment analysis of the KEGG signaling pathways conducted using the “clusterProfiler” package revealed significantly enriched KEGG pathways associated with correlated protein-coding genes. (D) A schematic diagram of the co-culture system illustrates MCL cells located on the upper side and macrophages on the lower side, separated by polycarbonate pore membranes with a pore size of 0.4 μm. (E) Mino and JEKO-1 cells were treated with the indicated concentrations of ibrutinib, with or without macrophages. Cell viability was evaluated using the CCK-8 assay, and control cells were treated with DMSO. (F-G) Cell apoptosis ratios were analyzed by flow cytometry. Mino and JEKO-1 cells were treated with either DMSO or 1 μM ibrutinib, and the percentages of Annexin V/PI (propidium iodide)-positive cells were measured. ****p < 0.0001.

    Journal: Journal of Advanced Research

    Article Title: Dialog between mantle cell lymphoma cells and lymphoma-associated macrophages underlies ibrutinib resistance

    doi: 10.1016/j.jare.2024.08.023

    Figure Lengend Snippet: Co-culture of MCL cells with macrophages. (A-B) The M2-to-M1 ratio of macrophages from both ibrutinib-sensitive and −resistant subjects was analyzed using macrophage samples derived from lymphoma and blood. (C) Enrichment analysis of the KEGG signaling pathways conducted using the “clusterProfiler” package revealed significantly enriched KEGG pathways associated with correlated protein-coding genes. (D) A schematic diagram of the co-culture system illustrates MCL cells located on the upper side and macrophages on the lower side, separated by polycarbonate pore membranes with a pore size of 0.4 μm. (E) Mino and JEKO-1 cells were treated with the indicated concentrations of ibrutinib, with or without macrophages. Cell viability was evaluated using the CCK-8 assay, and control cells were treated with DMSO. (F-G) Cell apoptosis ratios were analyzed by flow cytometry. Mino and JEKO-1 cells were treated with either DMSO or 1 μM ibrutinib, and the percentages of Annexin V/PI (propidium iodide)-positive cells were measured. ****p < 0.0001.

    Article Snippet: Human mantle cell lymphoma (MCL) cell lines Mino and JEKO-1 were obtained from the American Type Culture Collection (ATCC, Manassas, Virginia, USA).

    Techniques: Co-Culture Assay, Derivative Assay, Protein-Protein interactions, Pore Size, CCK-8 Assay, Control, Flow Cytometry

    Combination of CXCR2 inhibitor and ibrutinib displayed high synergistic inhibition of MCL growth. (A, B) The apoptosis of ibrutinib-treated cells was assessed using flow cytometry following treatment with CXCL5 or co-culture conditions. (C) Caspase-3 activity in Mino and JEKO-1 cells was measured under CXCL5 or co-culture treatments. (D) Compusyn software was employed to analyze the inhibition rates of malignant cells (MCLs) under ibrutinib, SB225002, and the combination of ibrutinib and SB225002 in a co-culture system. (E) The combined drug index (CI) of ibrutinib combined with SB225002 was analyzed using Compusyn software at different inhibition rates. (F) The dose-reduction index (DRI) of ibrutinib and SB225002 is presented. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Fa: Fraction affected.

    Journal: Journal of Advanced Research

    Article Title: Dialog between mantle cell lymphoma cells and lymphoma-associated macrophages underlies ibrutinib resistance

    doi: 10.1016/j.jare.2024.08.023

    Figure Lengend Snippet: Combination of CXCR2 inhibitor and ibrutinib displayed high synergistic inhibition of MCL growth. (A, B) The apoptosis of ibrutinib-treated cells was assessed using flow cytometry following treatment with CXCL5 or co-culture conditions. (C) Caspase-3 activity in Mino and JEKO-1 cells was measured under CXCL5 or co-culture treatments. (D) Compusyn software was employed to analyze the inhibition rates of malignant cells (MCLs) under ibrutinib, SB225002, and the combination of ibrutinib and SB225002 in a co-culture system. (E) The combined drug index (CI) of ibrutinib combined with SB225002 was analyzed using Compusyn software at different inhibition rates. (F) The dose-reduction index (DRI) of ibrutinib and SB225002 is presented. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Fa: Fraction affected.

    Article Snippet: Human mantle cell lymphoma (MCL) cell lines Mino and JEKO-1 were obtained from the American Type Culture Collection (ATCC, Manassas, Virginia, USA).

    Techniques: Inhibition, Flow Cytometry, Co-Culture Assay, Activity Assay, Software